Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Suprefact Nasal Spray.
| Pharmaceutical Form |
|---|
|
Nasal spray. |
Suprefact nasal spray contains 100 micrograms buserelin as buserelin acetate in 1 spray dose of aqueous solution containing benzalkonium chloride as preservative.
100 micrograms buserelin is equivalent to 105 micrograms buserelin acetate.
| Active Ingredient | Description | |
|---|---|---|
| Buserelin |
Buserelin is a synthetic peptide. It is a superactive analogue of natural gonadotrophin releasing hormone (gonadorelin, LHRH or GNRH). After an initial stimulation of gonadotrophin release, it down-regulates the hypothalanic-pituitary-gonadal axis. |
| List of Excipients |
|---|
|
Sodium chloride |
Box of 4 bottles each containing 10g solution and 4 spray pumps.
Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
PL 04425/0279
16 June 2006
| Drug | Countries | |
|---|---|---|
| SUPREFACT | Austria, Brazil, Canada, Spain, Netherlands, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
